Network Immunology Inc. is a privately owned Vancouver based biotechnology company, developing truly world-changing products. The HIV therapeutic and vaccine currently in development are based on Dr. Geoffrey W. Hoffmann’s symmetrical immune network theory, which he has developed over a period of 42 years. This theory describes how the immune system functions and learns as a [...]
It has been known for quite some time, that the brain is a network of neurons. Scientists in the field of Network Immunology have discovered that the immune system also functions as a network of cells. Both networks have memory, and the ability to learn from experience. Both networks possess a distinct sense of self, and the ability [...]
Posted on 23 August 2014.
Posted on 12 March 2014.
It has been known for quite some time, that the brain is a network of neurons.
Scientists in the field of Network Immunology have discovered that the immune system also functions as a network of cells.
Both networks have memory, and the ability to learn from experience.
Both networks possess a distinct sense of self, and the ability to differentiate, between self and other.
Network Immunology’s Chief Scientist, Geoffrey W. Hoffmann, who is both a physicist and immunologist by background, has discovered a mathematical equation that unites the two systems. They are separate, yet interconnected systems, that function along the same set of mathematical principles.
Network Immunology is the only company in the world, that is dedicated to building on this network framework of the immune system, and commercializing technologies that emerge from it.
Technologies under development include a preventive HIV vaccine, and a therapeutic for HIV positive individuals. There is now data for both of these products.
Posted on 10 August 2012.
Two experienced immunologists in the field of immune network science, Dr. Sybille Muller and Dr. Heinz Kohler, have joined Network Immunology. Dr. Muller has been appointed to the Board of Directors, and Dr. Heinz Kohler has been appointed Chairman of the Scientific Advisory Board. They discovered and researched the NetVac™ molecule that is a major component of the Network Immunology HIV vaccine.
Posted on 18 June 2012.
Dr. Matthew Parsons of McGill University has been appointed to the Scientific Advisory Board of Network Immunology. Dr. Parsons has contributed to important research around the NetVac™ molecule that is part of the HIV vaccine that Network Immunology is developing.
Posted on 04 April 2011.
Posted on 12 February 2011.
Network Immunology’s Chief Scientist, Geoffrey W. Hoffmann, has discovered a way to make a kind of antibody for humans that has been shown in studies with mice to be intimately associated with the suppression of the immune system. Network Immunology has filed a patent application for the use of this kind of antibody in the prevention and treatment of autoimmunity.
Posted on 10 January 2011.
On January 4th, 2011, Network Immunology Inc. filed provisional patent applications for it’s HIV vaccine and organ transplantation technologies. Both of these technologies have emerged from recent developments in Network Theory as applied to the immune system, and are closely related to each other at the level of the fundamental science. This was soon followed by a patent application for its MAB3 technology. On January 4th, 2012, the Company filed three Patent Convention Treaty applications, one for each of its technologies.
Network Immunology Inc. is seeking private equity financing in order to develop these technologies as quickly as possible.